Literature DB >> 19557432

A predicted functional single-nucleotide polymorphism of bone morphogenetic protein-4 gene affects mRNA expression and shows a significant association with cutaneous melanoma in Southern Italian population.

Mario Capasso1, Fabrizio Ayala, Roberta Russo, Rosa Anna Avvisati, Roberta Asci, Achille Iolascon.   

Abstract

PURPOSE: An altered expression of bone morphogenetic protein 4 (BMP4) has been found in malignant melanoma cells. We performed an association study to investigate the effect of putative functional single nucleotide polymorphisms (SNPs) of BMP4 on development of cutaneous melanoma (CM).
METHODS: We selected the predicted functional SNPs 6007 C/T (rs17563) and -3445 T/G (rs4898820) by the combination of three computational tools (FASTSNP, F-SNP and SNP Function Portal) plus another tool (SNP@promoter) skilled in identifying SNPs in transcription regulatory regions. Both SNPs were genotyped in a case-control study of 215 individuals with CM and 342 controls. We also evaluated the BMP4 hypothetical mRNA secondary structure by GeneBee program, the BMP4 mRNA levels and protein concentrations according to the genotype of two selected SNPs in transformed B-cells of 80 controls and in plasma samples of 38 controls, respectively.
RESULTS: The BMP4 T-allele was associated with CM (OR: 1.39, 95% CI: 1.09-1.78, P = 0.007). The T-allele was predicted to change mRNA structure and the BMP4 mRNA levels were significantly higher in T-allele carriers compared with C-allele carriers (P = 0.01), even the BMP4 protein plasma levels were higher among T-allele carries, but without reaching the statistical significance. No significant association was found between the SNP -3445 T/G alleles and either the risk of CM, or the mRNA levels of BMP4.
CONCLUSIONS: This study evidences the relevance of using bioinformatics tools in searching for cancer-associated gene polymorphisms and suggests that the predicted functional SNP 6007 C/T affects BMP4 gene expression and the risk to development of CM.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19557432     DOI: 10.1007/s00432-009-0628-y

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  29 in total

1.  Overexpression of BMP-2/4, -5 and BMPR-IA associated with malignancy of oral epithelium.

Authors:  Y Jin; G L Tipoe; E C Liong; T Y Lau; P C Fung; K M Leung
Journal:  Oral Oncol       Date:  2001-04       Impact factor: 5.337

2.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

3.  Bone morphogenetic protein-4 is overexpressed in colonic adenocarcinomas and promotes migration and invasion of HCT116 cells.

Authors:  Haiyun Deng; Ryouji Makizumi; T S Ravikumar; Huali Dong; Wancai Yang; Weng-Lang Yang
Journal:  Exp Cell Res       Date:  2007-01-10       Impact factor: 3.905

Review 4.  Bone morphogenetic proteins in development.

Authors:  B L Hogan
Journal:  Curr Opin Genet Dev       Date:  1996-08       Impact factor: 5.578

Review 5.  The bone morphogenetic protein family: multifunctional cellular regulators in the embryo and adult.

Authors:  J M Wozney
Journal:  Eur J Oral Sci       Date:  1998-01       Impact factor: 2.612

Review 6.  Current state of treatment for primary cutaneous melanoma.

Authors:  E S Chung; M S Sabel; V K Sondak
Journal:  Clin Exp Med       Date:  2004-10       Impact factor: 3.984

7.  A comprehensive expression survey of bone morphogenetic proteins in breast cancer highlights the importance of BMP4 and BMP7.

Authors:  Emma-Leena Alarmo; Tuula Kuukasjärvi; Ritva Karhu; Anne Kallioniemi
Journal:  Breast Cancer Res Treat       Date:  2006-09-21       Impact factor: 4.872

8.  Suppression of tumorigenesis and activation of Wnt signaling by bone morphogenetic protein 4 in human cancer cells.

Authors:  Tagvor G Nishanian; Jung-Sik Kim; Aaron Foxworth; Todd Waldman
Journal:  Cancer Biol Ther       Date:  2004-07-10       Impact factor: 4.742

9.  Rhesus monkey tryptophan hydroxylase-2 coding region haplotypes affect mRNA stability.

Authors:  G-L Chen; G M Miller
Journal:  Neuroscience       Date:  2008-06-08       Impact factor: 3.590

10.  A nonsynonymous substitution of cystatin A, a cysteine protease inhibitor of house dust mite protease, leads to decreased mRNA stability and shows a significant association with atopic dermatitis.

Authors:  Y Vasilopoulos; M J Cork; D Teare; I Marinou; S J Ward; G W Duff; R Tazi-Ahnini
Journal:  Allergy       Date:  2007-05       Impact factor: 13.146

View more
  16 in total

1.  Genetic variations in the transforming growth factor-beta pathway as predictors of survival in advanced non-small cell lung cancer.

Authors:  Moubin Lin; David J Stewart; Margaret R Spitz; Michelle A T Hildebrandt; Charles Lu; Jie Lin; Jian Gu; Maosheng Huang; Scott M Lippman; Xifeng Wu
Journal:  Carcinogenesis       Date:  2011-04-22       Impact factor: 4.944

2.  Polymorphism of bone morphogenetic protein 4 gene and its relationship with litter size of Jining Grey goats.

Authors:  M X Chu; L Lu; T Feng; R Di; G L Cao; P Q Wang; L Fang; Y H Ma; K Li
Journal:  Mol Biol Rep       Date:  2010-12-08       Impact factor: 2.316

3.  Upregulation of bone morphogenetic protein 4 is associated with poor prognosis in patients with hepatocellular carcinoma.

Authors:  Xiaodong Guo; Lu Xiong; Lin Zou; Jingmin Zhao
Journal:  Pathol Oncol Res       Date:  2012-02-15       Impact factor: 3.201

4.  Identification of polymorphisms in the 3'-untranslated region of the human pregnane X receptor (PXR) gene associated with variability in cytochrome P450 3A (CYP3A) metabolism.

Authors:  L Oleson; L L von Moltke; D J Greenblatt; M H Court
Journal:  Xenobiotica       Date:  2010-02       Impact factor: 1.908

5.  Phenotype characterization and sequence analysis of BMP2 and BMP4 variants in two Mexican families with oligodontia.

Authors:  Y Mu; Z Xu; C I Contreras; J S McDaniel; K J Donly; S Chen
Journal:  Genet Mol Res       Date:  2012-11-28

6.  Association of BMPR1A polymorphism, but not BMP4, with kidney size in full-term newborns.

Authors:  Mariusz Kaczmarczyk; Iwona Goracy; Beata Loniewska; Anna Kuprjanowicz; Agnieszka Binczak-Kuleta; Jeremy S Clark; Andrzej Ciechanowicz
Journal:  Pediatr Nephrol       Date:  2012-08-11       Impact factor: 3.714

7.  Anorectal atresia and variants at predicted regulatory sites in candidate genes.

Authors:  Tonia C Carter; Denise M Kay; Marilyn L Browne; Aiyi Liu; Paul A Romitti; Devon Kuehn; Mary R Conley; Michele Caggana; Charlotte M Druschel; Lawrence C Brody; James L Mills
Journal:  Ann Hum Genet       Date:  2012-11-06       Impact factor: 1.670

8.  Bone morphogenetic protein induces bone invasion of melanoma by epithelial-mesenchymal transition via the Smad1/5 signaling pathway.

Authors:  Jing Gao; Ryusuke Muroya; Fei Huang; Kengo Nagata; Masashi Shin; Ryoko Nagano; Yudai Tajiri; Shinsuke Fujii; Takayoshi Yamaza; Kazuhiro Aoki; Yukihiko Tamura; Mayuko Inoue; Sakura Chishaki; Toshio Kukita; Koji Okabe; Miho Matsuda; Yoshihide Mori; Tamotsu Kiyoshima; Eijiro Jimi
Journal:  Lab Invest       Date:  2021-09-09       Impact factor: 5.662

9.  Functional annotation and investigation of the 10q24.33 melanoma risk locus identifies a common variant that influences transcriptional regulation of OBFC1.

Authors:  Antonella Cardinale; Sueva Cantalupo; Vito Alessandro Lasorsa; Annalaura Montella; Flora Cimmino; Mariangela Succoio; Michiel Vermeulen; Marijke P Baltissen; Matteo Esposito; Marianna Avitabile; Daniela Formicola; Alessandro Testori; Ferdinando Bonfiglio; Paola Ghiorzo; Massimiliano Scalvenzi; Fabrizio Ayala; Nicola Zambrano; Mark M Iles; Mai Xu; Matthew H Law; Kevin M Brown; Achille Iolascon; Mario Capasso
Journal:  Hum Mol Genet       Date:  2022-03-21       Impact factor: 5.121

10.  The association between BMP4 gene polymorphism and its serum level with the incidence of LVH in hypertensive patients.

Authors:  G L Gu; Q Y Yang; R L Zeng; X L Xu
Journal:  J Transl Med       Date:  2015-01-16       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.